A potent stimulator of angiogenesis, vascular endothelial growth factor (VEGF) and its type 2 receptor Flk-1 have also been reported to be increased in DN animal models and patients, especially in the early stages [8,9]. Here, VEGFA is linked to liver dysplastic nodule.